Earlier in this month, Aptorum Group Limited (Nasdaq: APM), a Nasdaq-listed biopharmaceutical company, organized a fruitful Investors’ Gathering event at the Four Seasons Hotel, Hong Kong. Aptorum Group’s Executive Director and CEO, Ian Huen, along with CBO Darren Lui and Aeneas Group’s Vice-President Dr Chuen Yan Leung, gave informative speeches on current lead programmes and the groups latest therapeutic developments. It had been a great moment for us to connect, meet and share views with all guests. Click here to view more about the presentation and latest announcement by Aptorum Group.